To achieve this, a comprehensive whole-genome loss-of-function screen was conducted to identify genes that mediate tumour cell resistance to killing by CAR-T cells, as CAR-mediated T cell activation is not restricted to tumour antigen presentation on MHC molecules. The gene discussed is HLA-C; the disease is neoplasm.